Company profile: Veranova
1.1 - Company Overview
Company description
- Provider of research, development, and manufacturing of sophisticated, complex active pharmaceutical ingredients (APIs) for pharmaceutical and biotech industries, applying scientific expertise and diversified talent to create fresh approaches to resolving business issues and enhancing stakeholder value.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Veranova
Padagis
HQ: United States
Website
- Description: Provider of generic Rx and OTC pharmaceuticals, including Brinzolamide Ophthalmic Suspension for ocular hypertension/open-angle glaucoma, Naloxone HCl Nasal Spray for opioid overdose, and extended topical prescription creams, ointments, suspensions, gels, foams, sprays, patches, nasal, and suppositories. Offers Paragraph IV specialty products and U.S. and Israel manufacturing and distribution across multiple dosage forms, including controlled substances.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Padagis company profile →
Regulatory Compliance Associates
HQ: United States
Website
- Description: Provider of regulatory and quality consulting services for medical devices, pharmaceuticals, biologics, and compounding pharmacies. Offerings include regulatory affairs and submissions, compliance assurance, quality services, remediation strategy, FDA inspection preparation, cGMP guidance, and lab testing (biocompatibility, toxicology, sterility assurance, stability) to support product development and lifecycle needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Regulatory Compliance Associates company profile →
Calyx
HQ: United States
Website
- Description: Provider of medical imaging, eClinical, and regulatory solutions and services to solve complex challenges in clinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Calyx company profile →
Diaceutics
HQ: United Kingdom
Website
- Description: Provider of analytics, software, services and consulting that help pharmaceutical companies integrate diagnostic testing into treatment pathways, offering DXRX – The Diagnostic Network for collaboration and global real-world testing data, DXRX Data Solutions, DXRX Marketplace, DXRX Signal for testing behavior alerts, and insights via DXRX Physician Mapping and DXRX Lab Mapping.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diaceutics company profile →
Surepharm
HQ: United Kingdom
Website
- Description: Provider of pharmaceutical contract manufacturing and assembly services for solid dose medicinal and healthcare products, including generic and branded formulations. Offers formulation development; tablet and hard shell capsule manufacturing to GMP; blister packing with child-resistant options; pots/bottles filling; and analytical support, pilot batch management, and stability studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Surepharm company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Veranova
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Veranova
2.2 - Growth funds investing in similar companies to Veranova
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Veranova
4.2 - Public trading comparable groups for Veranova
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →